Vontobel Holding’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
13,108
-7,846
| -37% | -$651K | ﹤0.01% | 574 |
|
|
2025
Q1 | $1.7M | Buy |
20,954
+14,061
| +204% | +$1.14M | 0.01% | 477 |
|
|
2024
Q4 | $621K | Buy |
6,893
+351
| +5% | +$31.6K | ﹤0.01% | 730 |
|
|
2024
Q3 | $646K | Buy |
6,542
+1,233
| +23% | +$122K | ﹤0.01% | 713 |
|
|
2024
Q2 | $492K | Buy |
+5,309
| New | +$492K | ﹤0.01% | 772 |
|
|
2024
Q1 | – | Sell |
-21,277
| Closed | -$1.9M | – | 1169 |
|
|
2023
Q4 | $1.9M | Sell |
21,277
-9,554
| -31% | -$853K | 0.02% | 445 |
|
|
2023
Q3 | $2.25M | Buy |
30,831
+7,658
| +33% | +$559K | 0.02% | 403 |
|
|
2023
Q2 | $1.93M | Sell |
23,173
-24,217
| -51% | -$2.02M | 0.02% | 449 |
|
|
2023
Q1 | $3.61M | Buy |
47,390
+22,239
| +88% | +$1.69M | 0.03% | 333 |
|
|
2022
Q4 | $2.09M | Buy |
25,151
+15,809
| +169% | +$1.31M | 0.02% | 402 |
|
|
2022
Q3 | $741K | Sell |
9,342
-1,663
| -15% | -$132K | 0.01% | 613 |
|
|
2022
Q2 | $817K | Buy |
11,005
+4,605
| +72% | +$342K | 0.01% | 594 |
|
|
2022
Q1 | $575K | Buy |
+6,400
| New | +$575K | 0.01% | 752 |
|
|
2021
Q4 | – | Sell |
-6,000
| Closed | -$754K | – | 1220 |
|
|
2021
Q3 | $754K | Hold |
6,000
| – | – | 0.01% | 682 |
|
|
2021
Q2 | $812K | Hold |
6,000
| – | – | 0.01% | 643 |
|
|
2021
Q1 | $814K | Hold |
6,000
| – | – | 0.01% | 567 |
|
|
2020
Q4 | $845K | Buy |
+6,000
| New | +$845K | 0.01% | 515 |
|